2Wald DS, Law M, Morris JK, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials[J]. Am J Med,2009,122(3) :290-300.
3Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document[J], Blood Press,2009,18 (6) :308-347.
4Ross DF, Zou GY. A simplified approach to the treatment of uncomplicated hypertension, a cluster randomized, eontrolled trial [J]. Hypertension,2009,53(4) :646-653.
5Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis[J]. Hypertension,2010,55(2) : 399-407.
6Perreault S, Dragomir A, Roy L, et al. Adherence level of antihypertensive agents in coronary artery disease[J]. Br J Clin Pharmacol,2010,69(1) :74-84.
7Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients[J]. Circulation, 2009, 120 (16) : 1598-1605.
8Kettani FZ, Dragomir A, Cote R, etal. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for pri mary prevention[J]. Stroke, 2009,40 (1) : 213-220.
9Jamerson K, Weber MA, Bakris GL, et a l. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients [J]. N Engl J Med,2008,359(23) :2417-2428.
10Bakris GL, Sarafidis PA, Weir MR, et al. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH) : a prespecified secondary analysis of a randomised controlled trial[J]. Lancet,2010,375 (9721): 1173-1181.
8Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mo~lity: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, 2002, 360:1903-1913.
9Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology. Journal of Hypertension, 2007, 25 : 1105-1157.
10Kjeldsen SE, Aksnes TA, Sierra A, et al. Amlodipine and valsartan: calcium channel blockers/angiotensin Ⅱ receptor blockers combination for hypertension. Therapy,2007, 4: 31-40.
1Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC prac- tice guidelines for the management of arterial hypertension[J]. Blood Press,2014,23(1) :3-16.
2James PA, Oparil S, Carter BL, et al. 2014 evidence-based guide- line for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national com- mittee (JNC 8)[J]. JAMA,2014,311(5) :507-520.
3Czarnecka D, Koch EM, Gottwald-Hostalek U. Benefits of a fixed dose combination of bisoprolol and amlodipine in the treatment of hypertension in daily practice: results of more than 4 000 patients [J]. Curt Med Res Opin,2015,31(5) :875-881.
4Laurent S, Parati G, Chazova I, et al. Randomized evaluation of a novel, fixed-dose combination of perindopril 3. 5 mg/amlodipine 2.5 mg as a first-step treatment in hypertension[J].J Hypertens, 2015,33(3) :653-661.
5Rakugi H, Nakata E, Sasaki E, et al. Evaluation of the efficacy and tolerability of fixed-dose combination therapy of azilsartan and amlodipine besylate in Japanese patients with grade I to II essen tial hypertension[J]. Clin Ther,2014,36(5) :711- 721.
6Yan P, Fan W, Clinical trial investigators. The efficacy and safety of fixed-dose combination of amlodipine/benazepril in Chinese es- sential hypertensive patients not adequately controlled with benaz- epril monotherapy: a multicenter, randomized, double-blind, double-dummy, parallel-group clinical trial[J]. Clin Exp Hyper- tens,2014,36(4) :268-274.
7Roas S, Bernhart F, Schwarz M, et al. Antihypertensive combi- nation therapy in primary care offices~ results of a cross-sectional survey in Switzerland[J]. Int J Gen Med, 2014,7: 549-556.
8Erdine S. Compliance with the treatment of hypertension: the po- tential of combination therapy[J]. J Clin Hypertens (Greenwich), 2010,12(1) :41- 46.
9Chrostowska M, Narkiewicz K. Improving patient compliance with hypertension treatment: mission possible? [J]. Curt Vasc Pharmacol, 2010,8 ( 6 ) : 804-807.
10Min JY, Min KB, Hong JM, et al. Compliance and persistence of free-combination antihypertensive therapy versus single-pill combi- nation in Korean hypertensive patients[J]. Int J Cardiol, 2013,168 (4) :4576-4577.
